Document is current
Any future updates will be listed below
-
Authors
De Bruyn, Astrid https://orcid.org/0000-0002-1252-4982
Langouche, Lies https://orcid.org/0000-0002-8564-6809
Vander Perre, Sarah
Gunst, Jan https://orcid.org/0000-0003-2470-6393
Van den Berghe, Greet https://orcid.org/0000-0002-5320-1362
-
Funding
Funding for this research was provided by:
European Union's Horizon 2020 research and innovation program (AdvG 2017-785809)
Research Foundation Flanders (G.0C78.17N, G.0C78.17N)
Methusalem Program funded by the Flemish Government (METH14/06, METH14/06)
Universitaire Ziekenhuizen Leuven, KU Leuven (Postdoctoral research fellowship)
- License Information
-
More Information
Article History
Received: 27 January 2021
Accepted: 26 February 2021
First Online: 11 March 2021
Declarations
:
: This is a secondary analysis of the multicenter (Leuven, BE, Hasselt, BE) EPaNIC randomized controlled trial (ClinicalTrials.gov NCT00512122, <i>n</i> = 4640). The institutional ethical review boards of the participating centers approved the study protocol. Written informed consent was obtained from the patients or next of kin.
: Not applicable.
: The authors declare that they have no competing interests.
